Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Keisuke Hosoki"'
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract This study assessed whether perioperative management is associated with postoperative acute exacerbations (AEs) in interstitial lung disease (ILD) patients. Using secondary data from the study “Postoperative acute exacerbation of interstit
Externí odkaz:
https://doaj.org/article/bb73eae16c524afb96810d478c1663d2
Autor:
Kanji Uchida, Keisuke Hosoki, Yu Mikami, Hirokazu Urushiyama, Kunihiko Souma, Gaku Kawamura, Takahide Nagase, Taisuke Jo
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Introduction Patients with interstitial lung disease (ILD) are known to develop an acute exacerbation (AE) after surgery. Previous studies have evaluated the predictors of postoperative AE. However, it remains unclear whether the results of those stu
Externí odkaz:
https://doaj.org/article/ddad434845ec4e7a92d4454b355ec74d
Autor:
Takae Tanosaki, Yu Mikami, Hideo Shindou, Tomoyuki Suzuki, Tomomi Hashidate-Yoshida, Keisuke Hosoki, Shizuko Kagawa, Jun Miyata, Hiroki Kabata, Katsunori Masaki, Ryuji Hamamoto, Hidenori Kage, Naoya Miyashita, Kosuke Makita, Hirotaka Matsuzaki, Yusuke Suzuki, Akihisa Mitani, Takahide Nagase, Takao Shimizu, Koichi Fukunaga
Publikováno v:
Inflammation. 45:1765-1779
Chronic obstructive pulmonary disease (COPD) is primarily caused by inhalation of cigarette smoke and is the third leading cause of death worldwide. Pulmonary surfactant, a complex of phospholipids and proteins, plays an essential role in respiration
Naftopidil reduced the proliferation of lung fibroblasts and bleomycin‐induced lung fibrosis in mice
Autor:
Hirotaka Matsuzaki, Yoshihisa Hiraishi, Shinya Nagasaka, Yasuhiro Yamauchi, Yu Mikami, Yasuhiro Terasaki, Hiroyuki Tamiya, Satoshi Noguchi, Youko Endo, Keisuke Hosoki, Mika Terasaki, Kunihiko Souma, Takashi Ishii, Akihisa Mitani, Akira Shimizu, Kosuke Makita, Hirokazu Urushiyama, Takahide Nagase, Shinobu Kunugi, Hideaki Isago, Nariaki Kokuho
Publikováno v:
Journal of Cellular and Molecular Medicine
Naftopidil, an α‐1 adrenoceptor antagonist with few adverse effects, is prescribed for prostate hyperplasia. Naftopidil inhibits prostate fibroblast proliferation; however, its effects on lung fibroblasts and fibrosis remain largely unknown. Two n
Autor:
Keisuke Hosoki, Yu Mikami, Kazuko Miyakawa, Susumu Nakae, Takahide Nagase, Yoshihisa Hiraishi, Hirokazu Urushiyama, Masafumi Horie, Naoya Miyashita, Yasuhiro Yamauchi, Kensuke Fukuda, Akira Saito, Takashi Ishii, Akihisa Mitani, Kosuke Makita, Hirotaka Matsuzaki, Eri Shimura, Satoshi Noguchi
Publikováno v:
Allergy. 76(1)
TitleA mouse model of asthma–chronic obstructive pulmonary disease overlap induced by intratracheal papain
Autor:
Keisuke Hosoki, Yu Mikami, Kanji Uchida, Taisuke Jo, Kunihiko Souma, Gaku Kawamura, Takahide Nagase, Hirokazu Urushiyama
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BMJ Open Respiratory Research
BMJ Open Respiratory Research
IntroductionPatients with interstitial lung disease (ILD) are known to develop an acute exacerbation (AE) after surgery. Previous studies have evaluated the predictors of postoperative AE. However, it remains unclear whether the results of those stud
Autor:
Keisuke Hosoki, Naomi Yamashita, Takahide Nagase, Naohide Yamashita, Takashi Ishii, Yuichi Nikura
Publikováno v:
The Journal of Immunology. 198:3637-3649
Acute exacerbation of chronic obstructive pulmonary disease (COPD) is often induced by infection and often has a poor prognosis. Bacterial LPS activates innate immune receptor TLR4 followed by activation of a transcriptional factor IFN regulatory fac
Autor:
Keisuke Hosoki, Yu Mikami, Takahide Nagase, Hirotaka Matsuzaki, Naoya Miyashita, Kosuke Makita
Publikováno v:
Airway cell biology and immunopathology.
Publikováno v:
Clinical Problems.
Autor:
Goh Tanaka, Taisuke Jo, S. Kunihiko, Takahide Nagase, Hirokazu Urushiyama, Takahiro Ando, Yasuhiro Yamauchi, Akihisa Mitani, Hirotoshi Matsui, Hideo Yasunaga, Yuu Mikami, Keisuke Hosoki
Publikováno v:
B45. COPD: TREATMENT.